Real-Life Education Made Simple: STI Adopts DepEd’s Enhanced SHS Program To Introduce Flexible Electives

STI’s Education for Real Life philosophy continues with a program designed to help students learn with clearer purpose.

Palme d’or And Beyond: The Complete 79th Cannes Winners List

The 79th Festival de Cannes closed its Competition by honoring powerful films, standout performances, and visionary filmmakers from across the global cinema landscape.

What Sskait Means In 2025 And Beyond

Sskait continues to grow beyond trends, showing how Filipino humor, storytelling, and community can build a lasting digital legacy for readers.

Penélope Cruz On LGBTQ+ Cinema And Almodóvar

Penélope Cruz used Cannes to speak about LGBTQ+ stories, fairness, and how cinema can carry convictions beyond the screen.

Pres. Duterte ‘Most Hopeful’ About Potential China-Made Vaccine

Is a COVID-19 vaccine on its way? According to Roque, Moderna’s potential vaccine is already on its third phase of clinical trials.

Pres. Duterte ‘Most Hopeful’ About Potential China-Made Vaccine

57
57

How do you feel about this story?

Like
Love
Haha
Wow
Sad
Angry

President Rodrigo R. Duterte is “most hopeful” about the potential coronavirus disease 2019 (Covid-19) vaccine being developed by China, Malacañang said Thursday.

Presidential Spokesperson Harry Roque said Duterte prefers a China-made vaccine even as several countries are on a race to be the first to come up with a vaccine against Covid-19.

“The President is most hopeful with China but he has also said that Johnson and Johnson is on track,” Roque said in a virtual Palace briefing.

Citing reports, he said Moderna’s potential vaccine is also showing “very promising results.”

“Mayroon pong latest information on Moderna, mukha daw pong it has very promising results doon sa kaniyang third phase ng clinical trials (There is latest information on Moderna. It seems like its third phase of clinical trials is showing very promising results),” Roque said.

He said the governments of the Philippines and Russia are also coordinating on the latter’s potential Covid-19 vaccine, Sputnik V, since clinical trials will take place in both countries.

“Nakikipag-ugnayan pa rin po tayo dahil kinakailangan dumaan pa rin sa (We are also coordinating with the Russian authorities as far as the Russian Sputnik is concerned because it still needs to undergo) third clinical trial both in Russia and in the Philippines,” Roque said.

He also mentioned the potential vaccine being developed in England but clinical trials were temporarily stopped.

Roque said the global race to develop a Covid-19 vaccine would benefit countries like the Philippines.

“Now alam ninyo naman po kasi ang nature ng pharmaceutical industries, nag-uunahan po iyan, which is good for us. Nag-uunahan iyan at alam po nila kung sino mauna, sila po iyong kikita nang pinakamalaki (You know the nature of pharmaceutical industries, they’re racing to develop a vaccine, which is good for us. They’re on a race because they know that the first one to make it would earn the most),” he said.

Roque noted that the country would be putting its hopes that a vaccine would be developed without too much delay.

“So let’s hope that the free market this time will really come to our rescue and will incentivize the drug manufacturers to come up with (a) vaccine sooner than later,” he said.

Duterte earlier said the government would purchase the most affordable vaccine that will be sold due to budget constraints.

He also said he would seek a discount from China and Russia on the Covid-19 vaccines that each of the two countries developed and promised to supply the Philippines with.

Despite lacking funds, the President assured that the government would provide free vaccines to the disadvantaged once these are available.

In his first speech before the United Nations General Assembly, Duterte called for “universal access” to a Covid-19 vaccine, saying it is the only way to beat the pandemic.

He emphasized the need for “rich and poor nations” to have access to the vaccine. (PNA)